We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
+14.73%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.51B
AUM Growth
-$25.3M
(-1.6%)
Cap. Flow
-$166M
Cap. Flow
% of AUM
-11.02%
Top 10 Holdings %
Top 10 Hldgs %
21.48%
Holding
1,502
New
400
Increased
305
Reduced
321
Closed
403
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vipshop
VIPS
|
+$11.8M |
| 2 |
New Oriental
EDU
|
+$11.7M |
| 3 |
Li Auto
LI
|
+$10.4M |
| 4 |
HES
Hess
HES
|
+$9.96M |
| 5 |
ACM Research
ACMR
|
+$7.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$20.8M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$15.7M |
| 3 |
Trip.com Group
TCOM
|
+$13.1M |
| 4 |
NEWR
New Relic, Inc.
NEWR
|
+$11.2M |
| 5 |
VMW
VMware, Inc
VMW
|
+$9.66M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.24% |
| 2 | Consumer Discretionary | 12.06% |
| 3 | Healthcare | 10.13% |
| 4 | Industrials | 10.12% |
| 5 | Energy | 5.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Algonquin Power & Utilities
AQN
$4.37B
| $73.1K | ﹤0.01% |
+11,570
| New | +$67.6K |
|
1052
PMV Pharmaceuticals
PMVP
$64M
| $72.8K | ﹤0.01% |
+23,500
| New | +$62.2K |
|
|
LLAP
1053
DELISTED
Terran Orbital Corporation
LLAP
| $71.3K | ﹤0.01% |
+62,540
| New | +$52.3K |
|
1054
CarParts.com
PRTS
$54M
| $69.8K | ﹤0.01% |
2,210
+680
| +44% | +$23K |
|
|
VTYX
1055
DELISTED
Ventyx Biosciences
VTYX
| $69.2K | ﹤0.01% |
+28,000
| New | +$266K |
|
|
ALLK
1056
DELISTED
Allakos
ALLK
| $68.3K | ﹤0.01% |
25,000
| – | – |
|
|
NXDR
1057
Nextdoor Holdings
NXDR
$1.03B
| $67.9K | ﹤0.01% |
35,903
-25,936
| -42% | -$45.8K |
|
1058
Eos Energy Enterprises
EOSE
$1.49B
| $67.4K | ﹤0.01% |
+61,801
| New | +$90.1K |
|
1059
Quad
QUAD
$506M
| $66.6K | ﹤0.01% |
+12,284
| New | +$59.9K |
|
1060
Upland Software
UPLD
$14.3M
| $64.6K | ﹤0.01% |
1,528
-1,166
| -43% | -$50.4K |
|
1061
AXT Inc
AXTI
$4.89B
| $64K | ﹤0.01% |
26,658
-2,200
| -8% | -$4.92K |
|
|
IVAC
1062
DELISTED
Intevac Inc
IVAC
| $63.9K | ﹤0.01% |
14,789
-9,711
| -40% | -$36.2K |
|
|
NBP
1063
NovaBridge Biosciences American Depositary Shares
NBP
$202M
| $63.7K | ﹤0.01% |
33,550
-5,921
| -15% | -$8.85K |
|
1064
Prelude Therapeutics
PRLD
$387M
| $61.3K | ﹤0.01% |
+14,346
| New | +$43.7K |
|
1065
OPAL Fuels
OPAL
$81.4M
| $57.1K | ﹤0.01% |
10,351
-10,768
| -51% | -$66.5K |
|
1066
Accuray
ARAY
$35.8M
| $55.4K | ﹤0.01% |
19,574
-4,426
| -18% | -$12.1K |
|
|
CONN
1067
DELISTED
Conn's Inc.
CONN
| $54.8K | ﹤0.01% |
12,352
-2,100
| -15% | -$6.92K |
|
|
KNTE
1068
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $54.5K | ﹤0.01% |
23,014
-9,295
| -29% | -$16.5K |
|
1069
Rimini Street
RMNI
$464M
| $54K | ﹤0.01% |
16,512
| – | – |
|
|
ITI
1070
DELISTED
Iteris, Inc.
ITI
| $53.6K | ﹤0.01% |
10,300
-5,700
| -36% | -$25.1K |
|
1071
Sight Sciences
SGHT
$424M
| $53.4K | ﹤0.01% |
10,355
-6,200
| -37% | -$19.1K |
|
|
WHWK
1072
Whitehawk Therapeutics
WHWK
$262M
| $53.3K | ﹤0.01% |
26,397
+4,500
| +21% | +$18.9K |
|
|
RGLS
1073
DELISTED
Regulus Therapeutics
RGLS
| $51.5K | ﹤0.01% |
40,260
| – | – |
|
|
SHCR
1074
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $49.3K | ﹤0.01% |
+45,614
| New | +$46.8K |
|
1075
Seer Inc
SEER
$120M
| $49.1K | ﹤0.01% |
25,295
| – | – |
|
Similar funds
PFBT
CCP
SP
HCS
SPC
GPCM
MCM
CC
Prelude Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, Prelude Capital Management held 1,502 positions worth $1.51B, down 1.6% from $1.53B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Prelude Capital Management withdrew a net $166M in Q4 2023, closing 403 positions and reducing 321 holdings. Its most notable exit was Activision Blizzard, an estimated $20.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Prelude Capital Management opened a new position in New Oriental worth $12.4M.
- Prelude Capital Management's largest Q4 2023 buy was New Oriental: 168,713 shares worth $12.4M.
- Prelude Capital Management added most to Vipshop in Q4 2023, an estimated $11.8M increase.
- Prelude Capital Management's biggest Q4 2023 reduction was NVIDIA, cutting an estimated $7.3M.
- Prelude Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $20.8M.
- Prelude Capital Management's ten largest holdings make up 21% of its $1.51B portfolio in Q4 2023.
- Prelude Capital Management opened 400 new positions and closed 403 in Q4 2023.
- Prelude Capital Management's portfolio value fell 1.6% quarter-over-quarter to $1.51B.
Based on Prelude Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.